UBS Group
THACU

UBS Group’s Thrive Acquisition Corporation Unit THACU Stock Holding History

UBS Group’s Portfolio THACU Stock Details THACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-528
Closed -$5.46K – 11465
2022
Q4 		$5.46K Hold
528
– – ﹤0.01% 9179
2022
Q3 		$5K Hold
528
– – ﹤0.01% 9290
2022
Q2 		$5K Hold
528
– – ﹤0.01% 8997
2022
Q1 		$5K Sell
528
-980
-65% -$9.88K ﹤0.01% 9232
2021
Q4 		$15K Buy
+1,508
New +$15.2K ﹤0.01% 8293

UBS Group's THACU Position: Q1 2023 in Review

UBS Group sold out of Thrive Acquisition Corporation Unit (THACU) in Q1 2023, closing a stake of 528 shares — an estimated $5.46K sold.

UBS Group first reported a position in THACU in Q4 2021 and held it in 5 quarters. The position peaked at $15K in Q4 2021. 0 funds tracked by Wall St. Rank hold THACU as of Q1 2023.

  • UBS Group reported no remaining Thrive Acquisition Corporation Unit position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 528 Thrive Acquisition Corporation Unit shares in Q1 2023, an estimated $5.46K.
  • UBS Group first reported a position in Thrive Acquisition Corporation Unit in Q4 2021 and held it in 5 quarters.
  • UBS Group's Thrive Acquisition Corporation Unit position peaked at $15K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Unit as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.